A PHASE I, OPEN-LABEL, RANDOMIZED, ADAPTIVE, CROSS-OVER STUDY TO DETERMINE THE RELATIVE BIOAVAILABILITY OF NIZUBAGLUSTAT CAPSULES COMPARED TO ORALLY DISPERSIBLE TABLETS AND THE FOOD EFFECT IN HEALTHY VOLUNTEERS

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510058-17-00

Acronym

AZA-001-31-03

Enrollment

Registered

2024-02-27

Start date

2024-03-12

Completion date

2025-01-06

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycosphingolipid lysosomal storage disorders

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026